Risk factors for potential drug-drug interactions of statins in patients with acute coronary syndrome

Risk factors for potential drug-drug interactions of statins in patients with acute coronary syndrome

Abstract The aim of our study was to assess risk factors for potential drug-drug interactions (pDDIs) of statins across different phases of treatment of acute coronary syndrome (ACS) patients: from the point of first medical contact to the coronary angiography (first phase), after coronary angiograp...

Full description

Bibliographic Details
Main Authors:	Ana V. Pejčić, Slobodan M. Janković, Goran Davidović
Format:	Article
Language:	English
Published:	Universidade de São Paulo 2022-06-01
Series:	Brazilian Journal of Pharmaceutical Sciences
Subjects:	Statins Acute coronary syndrome Drug-drug interactions Risk factors
Online Access:	http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1984-82502022000100602&tlng=en

Similar Items

New Antithrombotic Drugs in Acute Coronary Syndrome
by: Bastiaan Zwart, et al.
Published: (2020-06-01)

Treatment of dyslipidemia in acute coronary syndrome
by: Satyavir Yadav, et al.
Published: (2024-03-01)

Prior statin use and the incidence of in-hospital arrhythmia in acute coronary syndrome: A systematic review and meta-analysis
by: Kevin Wibawa, et al.
Published: (2023-01-01)

Statins: Side effects and drug interactions
by: Kažić Tomislav
Published: (2011-01-01)

Potential drug-drug interactions in drug therapy for older adults with chronic coronary syndrome at hospital discharge: A real-world study
by: Mei Zhao, et al.
Published: (2022-08-01)

MYOPATHY CAUSED BY THE INTERACTION OF COLCHICINE AND STATINS
by: A. S. Kazakov, et al.
Published: (2018-09-01)

Upfront Combination of Statin and Ezetimibe for Patients With Acute Coronary Syndrome: Time for a New Approach?
by: Lina Ya'Qoub, et al.
Published: (2023-09-01)

Recreational drug use among young, hospitalized patients with acute coronary syndrome: A retrospective study
by: Femke M.J. Gresnigt, et al.
Published: (2022-01-01)

Role of Statin Drugs for Polycystic Ovary Syndrome
by: Lisa Cassidy Vu, et al.
Published: (2017-03-01)

Comparative Effectiveness of Generic Atorvastatin and Lipitor® in Patients Hospitalized with an Acute Coronary Syndrome
by: Cynthia A. Jackevicius, et al.
Published: (2016-04-01)

Acute coronary syndrome: how to reduce the residual inflammatory risk?
by: V. I. Shalnev
Published: (2020-03-01)

Efficacy of single high-dose statin prior to percutaneous coronary intervention in acute coronary syndrome: a systematic review and meta-analysis
by: Bryan Gervais de Liyis, et al.
Published: (2024-04-01)

Prevalence and predictors of potential drug-drug interactions
by: Nikolic Bozana, et al.
Published: (2014-04-01)

Safety and Efficacy of PCSK9 Inhibitors in Patients with Acute Coronary Syndrome Who Underwent Coronary Artery Bypass Grafts: A Comparative Retrospective Analysis
by: Giuseppe Nasso, et al.
Published: (2024-02-01)

Herbs with anti-lipid effects and their interactions with statins as a chemical anti- hyperlipidemia group drugs: A systematic review
by: Hojjat Rouhi-Boroujeni, et al.
Published: (2015-08-01)

Predictors of Nonuse of a High‐Potency Statin After an Acute Coronary Syndrome: Insights From the Stabilization of Plaques Using Darapladib‐Thrombolysis in Myocardial Infarction 52 (SOLID‐TIMI 52) Trial
by: Alon Eisen, et al.
Published: (2017-01-01)

Short Term Comparison Between Safety and Efficacy of Rosuvastatin 40 mg and Atorvastatin 80 mg in Patients with Acute Coronary Syndrome
by: Sh. A. Mostafa, et al.
Published: (2018-11-01)

The effects of pharmaceutical care provision on patients with acute coronary syndromes and
by: M Rungsilp, et al.
Published: (2008-06-01)

Impact of metformin on statin‐associated myopathy risks in dyslipidemia patients
by: Keunhyeong Bak, et al.
Published: (2023-08-01)

Drug-induced esophageal injuries with an atypical presentation mimicking acute coronary syndrome
by: Guda Merdassa Roro, et al.
Published: (2021-12-01)

European recommendations on therapy of dyslipidemias – 2016 Lipid-lowering therapy in patients with acute coronary syndrome and percutaneous coronary interventions
by: Y. A. Karpov, et al.
Published: (2016-12-01)

Six-month adherence to Statin use and subsequent risk of major adverse cardiovascular events (MACE) in patients discharged with acute coronary syndromes
by: Gaoqiang Xie, et al.
Published: (2017-08-01)

HIGH DOSES OF STATINS BEFORE PERCUTANEOUS CORONARY INTERVENTION: WHETHER THERE ARE REASONS TO USE?
by: I. S. Yavelov, et al.
Published: (2017-09-01)

Drug–Drug Interactions in Patients with Acute Respiratory Distress Syndrome
by: Thorsten Bischof, et al.
Published: (2024-02-01)

Acute Adrenal Insufficiency Associated with Acute Coronary Syndrome
by: Youngji Kim, et al.
Published: (2014-08-01)

The results of staged endovascular revascularization with use of stents with third generations of drug-eluting and biodegradable polymer in patients with acute coronary syndrome and multivessel coronary artery disease
by: Aleksandr V. Bocharov, et al.
Published: (2019-04-01)

Effects of Preoperative Statin on Acute Kidney Injury After Off‐Pump Coronary Artery Bypass Grafting
by: Jungchan Park, et al.
Published: (2019-04-01)

Impact of Paclitaxel-Eluting Balloons Compared to Second-Generation Drug-Eluting Stents for of In-Stent Restenosis in a Primarily Acute Coronary Syndrome Population
by: Guillaume Marquis-Gravel, et al.
Published: (2017-09-01)

Time Course of Ischemic and Bleeding Burden in Elderly Patients With Acute Coronary Syndromes Randomized to Low‐Dose Prasugrel or Clopidogrel
by: Gabriele Crimi, et al.
Published: (2019-01-01)

Factors associated with statin-related adverse muscular events in adult dyslipidemic outpatients
by: Paula Ferreira Castro, et al.
Published: (2018-04-01)

Statins: a repurposed drug to fight cancer
by: Wen Jiang, et al.
Published: (2021-07-01)

Efficacy and safety of the intensive dose of rosuvastatin 40 mg/day in patients with acute coronary syndrome and at high risk of cardiovascular disease-ROSUVEES-2
by: Chetan P. Shah, et al.
Published: (2016-11-01)

Interacciones entre los alimentos y las estatinas Interactions between foodstuffs and statins
by: S. de Andrés, et al.
Published: (2004-07-01)

Clopidogrel-statin interaction: A missing links
by: Todorović Zoran M., et al.
Published: (2016-01-01)

Montelukast and Acute Coronary Syndrome: The Endowed Drug
by: Basil Mohammed Alomair, et al.
Published: (2022-09-01)

Potential drug interactions with statins: Estonian register-based study
by: Gavronski Maia, et al.
Published: (2015-04-01)

Ticagrelor vs. Clopidogrel in Acute Coronary Syndrome Patients With Chronic Kidney Disease After New-Generation Drug-Eluting Stent Implantation
by: Ji Woong Roh, et al.
Published: (2022-01-01)

Frequency and predictors of potential drug: Drug interactions in hospitalized patients with Parkinson's diseases
by: Aleksić Dejan Z., et al.
Published: (2021-01-01)

Change in Trajectories of Adherence to Lipid‐Lowering Drugs Following Non‐Fatal Acute Coronary Syndrome or Stroke
by: Arsène Zongo, et al.
Published: (2019-12-01)

High-intensity statin therapy yields better outcomes in acute coronary syndrome patients: a meta-analysis involving 26,497 patients
by: Shiyong Yu, et al.
Published: (2020-08-01)